Preconceptional Counseling in Women with Hyperthyroidism

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2024 Feb 24

PMID 38399522

Authors

Luminita Nicoleta Cima

Mihaela Tarna

Carmen Sorina Martin

Anca Elena Sirbu

Iulia Soare

Anca Maria Panaitescu

Nicolae Gica

Carmen Gabriela Barbu

Simona Fica

Affiliations

Soon will be listed here.

Abstract

Preconception evaluation of couples wishing to conceive is an important step toward a healthy pregnancy and it is especially important in people with a chronic condition or at genetic risk. The most common endocrine disorders in women at reproductive age are those involving the thyroid gland and it is well recognized that hyperthyroidism (HT), over-function of the thyroid gland, is associated with risks of maternal, fetal, and neonatal complications. The aim of this paper is to review the latest evidence regarding the components of preconception counseling in women with HT that contemplate a pregnancy. We also want to raise awareness among healthcare professionals about the importance of periconceptional counseling in improving pregnancy outcomes and avoid maternal and fetal complications related to thyroid dysfunction. In women with Graves' disease seeking pregnancy, it is essential to discuss all the treatment options along with the associated risks and benefits. Extensive prospective studies are still needed to understand the implications of current recommended strategies for the management of HT in preconception and during pregnancy.

References

Kahaly G, Bartalena L, Hegedus L, Leenhardt L, Poppe K, Pearce S . 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism. Eur Thyroid J. 2018; 7(4):167-186. PMC: 6140607. DOI: 10.1159/000490384. View

Ashkar C, Sztal-Mazer S, Topliss D . How to manage Graves' disease in women of childbearing potential. Clin Endocrinol (Oxf). 2022; 98(5):643-648. DOI: 10.1111/cen.14705. View

Panaitescu A, Nicolaides K . Maternal autoimmune disorders and fetal defects. J Matern Fetal Neonatal Med. 2017; 31(13):1798-1806. DOI: 10.1080/14767058.2017.1326904. View

Mahadik K, Choudhary P, Roy P . Study of thyroid function in pregnancy, its feto-maternal outcome; a prospective observational study. BMC Pregnancy Childbirth. 2020; 20(1):769. PMC: 7726876. DOI: 10.1186/s12884-020-03448-z. View

Sarkar S, Bischoff L . Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period. Semin Reprod Med. 2016; 34(6):317-322. DOI: 10.1055/s-0036-1593489. View

Hyer S, Pratt B, Newbold K, Hamer C . Outcome of Pregnancy After Exposure to Radioiodine In Utero. Endocr Pract. 2011; :1-10. DOI: 10.4158/EP10237.RA. View

Derakhshan A, Peeters R, Taylor P, Bliddal S, Carty D, Meems M . Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol. 2020; 8(6):501-510. PMC: 8168324. DOI: 10.1016/S2213-8587(20)30061-9. View

Yu W, Wu N, Li L, Wang J, Ouyang H, Shen H . SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS. Endocr Pract. 2019; 26(2):207-217. DOI: 10.4158/EP-2019-0221. View

Turunen S, Vaarasmaki M, Lahesmaa-Korpinen A, Leinonen M, Gissler M, MaNnisto T . Maternal hyperthyroidism and pregnancy outcomes: A population-based cohort study. Clin Endocrinol (Oxf). 2020; 93(6):721-728. DOI: 10.1111/cen.14282. View

10.

Li X, Liu G, Ma J, Zhou L . Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis. Clinics (Sao Paulo). 2015; 70(6):453-9. PMC: 4462563. DOI: 10.6061/clinics/2015(06)12. View

11.

Andersen S, Knosgaard L . Management of thyrotoxicosis during pregnancy. Best Pract Res Clin Endocrinol Metab. 2020; 34(4):101414. DOI: 10.1016/j.beem.2020.101414. View

12.

de Jong J, Verkooijen H, Valk G, Zelissen P, de Keizer B . High failure rates after (131)I therapy in Graves hyperthyroidism patients with large thyroid volumes, high iodine uptake, and high iodine turnover. Clin Nucl Med. 2013; 38(6):401-6. DOI: 10.1097/RLU.0b013e3182817c78. View

13.

Korevaar T, Muetzel R, Medici M, Chaker L, Jaddoe V, de Rijke Y . Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol. 2015; 4(1):35-43. DOI: 10.1016/S2213-8587(15)00327-7. View

14.

Tonacchera M, Chiovato L, Bartalena L, Cavaliere A, Vitti P . Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy. J Endocrinol Invest. 2019; 43(2):257-265. DOI: 10.1007/s40618-019-01148-w. View

15.

Song R, Lin H, Chen Y, Zhang X, Feng W . Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis. PLoS One. 2017; 12(7):e0180108. PMC: 5495385. DOI: 10.1371/journal.pone.0180108. View

16.

Yoshihara A, Yoshimura Noh J, Watanabe N, Mukasa K, Ohye H, Suzuki M . Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. Thyroid. 2015; 25(10):1155-61. DOI: 10.1089/thy.2014.0581. View

17.

Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K . Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab. 2012; 97(7):2396-403. DOI: 10.1210/jc.2011-2860. View

18.

Miao Y, Xu Y, Teng P, Wang A, Zhang Y, Zhou Y . Efficacy of propylthiouracil in the treatment of pregnancy with hyperthyroidism and its effect on pregnancy outcomes: A meta-analysis. PLoS One. 2022; 17(3):e0265085. PMC: 8912150. DOI: 10.1371/journal.pone.0265085. View

19.

Andersen S, Knosgaard L, Olsen J, Vestergaard P, Andersen S . Maternal Thyroid Function, Use of Antithyroid Drugs in Early Pregnancy, and Birth Defects. J Clin Endocrinol Metab. 2019; 104(12):6040-6048. DOI: 10.1210/jc.2019-01343. View

20.

Morales D, Fonkwen L, M E Nordeng H . Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations. Br J Clin Pharmacol. 2021; 87(10):3890-3900. PMC: 11497346. DOI: 10.1111/bcp.14805. View